Bill Title: Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical manufacturers.

Sponsorship: Partisan Bill (Democrat 2)

Status: (Introduced - Dead) 2019-03-05 - Introduced, Referred to Assembly Health and Senior Services Committee [A5101 Detail]

---

Bill Drafts

Revision	Date	Format	Source	View
Introduced	2019-03-05	HTML/Text	Link	View

Amendments

Amendment	Date	Disposition	Format	Source	View
No bill amendments currently on file for New Jersey A5101

Supplemental Documents

Title	Description	Date	Format	Source	View
No supplemental documents for New Jersey A5101 currently on file.